Springbok Capital Management »

Acasti Pharma shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $47k 10k 4.63

More positions owned by Springbok Capital Management

Spdr Gold Tr Gold Shs (GLD)
Brighthouse Finl (BHF)
NVIDIA Corporation (NVDA)
Penumbra (PEN)
Micron Technology (MU)
Meta Platforms Cl A (META)
Clearwater Analytics Hldgs I Cl A (CWAN)
Norfolk Southern (NSC)
Warner Bros Discovery Com Ser A (WBD)
Amazon (AMZN)
Chart Industries (GTLS)
PNM Resources (TXNM)
Seagate Technology Hldngs Pl Ord Shs (STX)
Arcellx Common Stock (ACLX)
Versant Media Group Com Cl A (VSNT)

View all positions for Springbok Capital Management

Top funds holding Acasti Pharma

HPM Partners
Nantahala Capital Management
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Renaissance Technologies
Jane Street
Susquehanna International
Citadel Advisors
Marshall Wace
Connective Capital Management
Birchview Capital
Diametric Capital
XTX Topco
UBS Group

View all funds holding Acasti Pharma